Skip to main content

Advertisement

Log in

Tauopathies and synucleinopathies: Do cerebrospinal fluid β-amyloid peptides reflect disease-specific pathogenesis?

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

To evaluate variations in amyloid beta (Aβ) peptide pattern in cerebrospinal fluid (CSF) in neurodegenerative disorders. A recently established quantitative urea-based Aβ-sodium-dodecylsulfate-polyacrylamide-gel-electrophoresis with western immunoblot (Aβ-SDS-PAGE/immunoblot) revealed a highly conserved Aβ peptide (Aβ1-37, 1-38, 1-39, 1-40, 1-42) pattern in CSF. We asked whether the variation might be useful to further elucidate the overlap between or distinctions among neurodegenerative diseases in Aβ-processing.

We used the Aβ-SDS-PAGE/immunoblot to investigate CSF for disease-specific Aβ peptide patterns. CSF samples from 96 patients with mainly clinically diagnosed Alzheimer’s disease (n = 15), progressive supranuclear palsy (n = 20), corticobasal degeneration (n = 12), Parkinson’s disease (n = 11), multiple systems atrophy (n = 18), and dementia with Lewy-bodies (n = 20) were analysed as well a comparison group (n = 19).

The Aβ peptide patterns varied between tauopathies and synucleinopathies and between all diseases and the comparison group, possibly due to the influence of tau and α-synuclein on Aβ-processing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • N Andreasen K Blennow (2002) ArticleTitleBeta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease Peptides 23 1205–1214 Occurrence Handle12128078 Occurrence Handle10.1016/S0196-9781(02)00056-6 Occurrence Handle1:CAS:528:DC%2BD38XlsVOqt7Y%3D

    Article  PubMed  CAS  Google Scholar 

  • M Bibl H Esselmann M Otto P Lewczuk L Cepek E Ruther J Kornhuber J Wiltfang (2004) ArticleTitleCerebrospinal fluid amyloid beta peptide patterns in Alzheimer’s disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides Electrophoresis 25 2912–2918 Occurrence Handle15349929 Occurrence Handle10.1002/elps.200305992 Occurrence Handle1:CAS:528:DC%2BD2cXnvFejsbY%3D

    Article  PubMed  CAS  Google Scholar 

  • M Bibl B Mollenhauer H Esselmann P Lewczuk H-W Klafki K Sparbier A Smirnov L Cepek C Trenkwalder E Ruther J Kornhuber M Otto J Wiltfang (2006) ArticleTitleCSF amyloid-{beta}-peptides in Alzheimer’s disease, dementia with Lewy bodies and Parkinson’s disease dementia Brain 129 1177–1187 Occurrence Handle16600985 Occurrence Handle10.1093/brain/awl063

    Article  PubMed  Google Scholar 

  • GS Bloom K Ren CG Glabe (2005) ArticleTitleCultured cell and transgenic mouse models for tau pathology linked to beta-amyloid Biochim Biophys Acta 1739 116–124 Occurrence Handle15615631 Occurrence Handle1:CAS:528:DC%2BD2cXhtFahsrvJ

    PubMed  CAS  Google Scholar 

  • M Citron TS Diehl G Gordon AL Biere P Seubert DJ Selkoe (1996) ArticleTitleEvidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities Proc Natl Acad Sci USA 93 13170–13175 Occurrence Handle8917563 Occurrence Handle10.1073/pnas.93.23.13170 Occurrence Handle1:CAS:528:DyaK28XmvV2qt70%3D

    Article  PubMed  CAS  Google Scholar 

  • CM Clark S Xie J Chittams D Ewbank E Peskind D Galasko JC Morris DW McKeel SuffixJr M Farlow SL Weitlauf J Quinn J Kaye D Knopman H Arai RS Doody C DeCarli S Leight VM Lee JQ Trojanowski (2003) ArticleTitleCerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60 1696–1702 Occurrence Handle14676043 Occurrence Handle10.1001/archneur.60.12.1696

    Article  PubMed  Google Scholar 

  • CE Clarke (2004) ArticleTitleNeuroprotection and pharmacotherapy for motor symptoms in Parkinson’s disease Lancet Neurol 3 466–474 Occurrence Handle15261607 Occurrence Handle10.1016/S1474-4422(04)00823-3

    Article  PubMed  Google Scholar 

  • JG Culvenor CA McLean S Cutt BC Campbell F Maher P Jakala T Hartmann K Beyreuther CL Masters QX Li (1999) ArticleTitleNon-Abeta component of Alzheimer’s disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid Am J Pathol 155 1173–1181 Occurrence Handle10514400 Occurrence Handle1:CAS:528:DyaK1MXntFWmtrc%3D

    PubMed  CAS  Google Scholar 

  • OM El-Agnaf SA Salem KE Paleologou LJ Cooper NJ Fullwood MJ Gibson MD Curran JA Court DM Mann S Ikeda MR Cookson J Hardy D Allsop (2003) ArticleTitleAlpha-synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, including human plasma FASEB 17 1945–1947 Occurrence Handle1:CAS:528:DC%2BD3sXot1Kit7Y%3D

    CAS  Google Scholar 

  • AM Faghan MA Mintun RH Mach L Sang-Yoon CS Dence AR Shah GN LaRossa ML Spinner WE Klunk CA Mathis ST DeKosky JC Morris DM Holtzman (2006) ArticleTitleInverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans Ann Neurol 59 512–519 Occurrence Handle10.1002/ana.20730 Occurrence Handle1:CAS:528:DC%2BD28XjtV2ltr0%3D

    Article  CAS  Google Scholar 

  • MF Folstein SE Folstein PR McHugh (1975) ArticleTitle“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189–198 Occurrence Handle1202204 Occurrence Handle10.1016/0022-3956(75)90026-6 Occurrence Handle1:STN:280:DyaE28%2FntFKjtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • RA Frank D Galasko H Hampel J Hardy MJ de Leon PD Mehta J Rogers E Siemers JQ Trojanowski (2003) ArticleTitleBiological markers for therapeutic trials in Alzheimer’s disease. Proc., Biological Markers Working Group; NIA initiative on neuroimaging in Alzheimer’s disease Neurobiol Aging 24 521–536 Occurrence Handle12714109 Occurrence Handle10.1016/S0197-4580(03)00002-2

    Article  PubMed  Google Scholar 

  • S Gilman P Low N Quinn A Albanese Y Ben-Shlomo C Fowler H Kaufmann T Klockgether A Lang P Lantos I Litvan C Mathias E Oliver D Robertson I Schatz G Wenning (1998) ArticleTitleConsensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology Clin Auton Res 8 359–362 Occurrence Handle9869555 Occurrence Handle10.1007/BF02309628 Occurrence Handle1:STN:280:DyaK1M%2FosV2jsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • GG Glenner CW Wong V Quaranta ED Eanes (1984) ArticleTitleThe amyloid deposits in Alzheimer’s disease: their nature and pathogenesis Appl Pathol 2 357–369 Occurrence Handle6242724 Occurrence Handle1:STN:280:DyaL2s%2FgtVartg%3D%3D

    PubMed  CAS  Google Scholar 

  • E Gomez-Tortosa I Gonzalo S Fanjul MJ Sainz S Cantarero C Cemillan JG Yebenes T del Ser (2003) ArticleTitleCerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease Arch Neurol 60 1218–1222 Occurrence Handle12975286 Occurrence Handle10.1001/archneur.60.9.1218

    Article  PubMed  Google Scholar 

  • JP Guo T Arai J Miklossy PL McGeer (2006) ArticleTitleAbeta and tau form soluble complexes that may promote self aggregation of both into the insoluble form observed in Alzheimer’s disease Proc Natl Acad Sci USA 103 IssueID6 1953–1958 Occurrence Handle16446437 Occurrence Handle10.1073/pnas.0509386103 Occurrence Handle1:CAS:528:DC%2BD28Xhslehtbg%3D

    Article  PubMed  CAS  Google Scholar 

  • C Haass DJ Selkoe (1993) ArticleTitleCellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide Cell 75 1039–1042 Occurrence Handle8261505 Occurrence Handle10.1016/0092-8674(93)90312-E Occurrence Handle1:CAS:528:DyaK2cXnsVeksQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • J Hardy DJ Selkoe (2002) ArticleTitleThe amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics Science 297 353–356 Occurrence Handle12130773 Occurrence Handle10.1126/science.1072994 Occurrence Handle1:CAS:528:DC%2BD38Xls1Cju7s%3D

    Article  PubMed  CAS  Google Scholar 

  • B Holmberg B Johnels K Blennow L Rosengren (2003) ArticleTitleCerebrospinal fluid Abeta42 is reduced in multiple system atrophy but normal in Parkinson’s disease and progressive supranuclear palsy Mov Disord 18 186–190 Occurrence Handle12539213 Occurrence Handle10.1002/mds.10321

    Article  PubMed  Google Scholar 

  • AJ Hughes SE Daniel L Kilford AJ Lees (1992) ArticleTitleAccuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181–184 Occurrence Handle1564476 Occurrence Handle1:STN:280:DyaK383is1Omsg%3D%3D Occurrence Handle10.1136/jnnp.55.3.181

    Article  PubMed  CAS  Google Scholar 

  • F Hulstaert K Blennow A Ivanoiu HC Schoonderwaldt M Riemenschneider PP De Deyn C Bancher P Cras J Wiltfang PD Mehta K Iqbal H Pottel E Vanmechelen H Vanderstichele (1999) ArticleTitleImproved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF Neurology 52 1555–1562 Occurrence Handle10331678 Occurrence Handle1:STN:280:DyaK1M3mtVGhsw%3D%3D

    PubMed  CAS  Google Scholar 

  • A Iwai M Yoshimoto E Masliah T Saitoh (1995) ArticleTitleNon-A beta component of Alzheimer’s disease amyloid (NAC) is amyloidogenic Biochemistry 34 10139–10145 Occurrence Handle7640267 Occurrence Handle10.1021/bi00032a006 Occurrence Handle1:CAS:528:DyaK2MXntFCht7c%3D

    Article  PubMed  CAS  Google Scholar 

  • K Janek S Rothemund K Gast M Beyermann J Zipper H Fabian M Bienert E Krause (2001) ArticleTitleStudy of the conformational transition of A beta(1-42) using D-amino acid replacement analogues Biochemistry 40 5457–5463 Occurrence Handle11331010 Occurrence Handle10.1021/bi002005e Occurrence Handle1:CAS:528:DC%2BD3MXisFemsb0%3D

    Article  PubMed  CAS  Google Scholar 

  • KA Jellinger (2003) ArticleTitlePrevalence of Alzheimer lesions in Parkinson’s disease Mov Disord 18 1207–1208 Occurrence Handle14534932 Occurrence Handle10.1002/mds.10513

    Article  PubMed  Google Scholar 

  • K Jendroska AJ Lees W Poewe SE Daniel (1996) ArticleTitleAmyloid beta-peptide and the dementia of Parkinson’s disease Mov Disord 11 647–653 Occurrence Handle8914090 Occurrence Handle10.1002/mds.870110609 Occurrence Handle1:STN:280:DyaK2s%2FntFWltw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • K Jendroska M Kashiwagi J Sassoon SE Daniel (1997) ArticleTitleAmyloid beta-peptide and its relationship with dementia in Lewy body disease J Neural Transm Suppl 51 137–144 Occurrence Handle9470134 Occurrence Handle1:CAS:528:DyaK1cXht12jsL4%3D

    PubMed  CAS  Google Scholar 

  • JK Kawooya TL Emmons PA Gonzalez-DeWhitt MC Camp SC D’Andrea (2003) ArticleTitleElectrophoretic mobility of Alzheimer’s amyloid-beta peptides in urea-sodium dodecyl sulfate-polyacrylamide gel electrophoresis Anal Biochem 323 103–113 Occurrence Handle14622964 Occurrence Handle10.1016/j.ab.2003.08.027 Occurrence Handle1:CAS:528:DC%2BD3sXovVWgurY%3D

    Article  PubMed  CAS  Google Scholar 

  • P Kurosinski M Guggisberg J Gotz (2002) ArticleTitleAlzheimer’s and Parkinson’s disease–overlapping or synergistic pathologies? Trends Mol Med 8 3–5 Occurrence Handle11796255 Occurrence Handle10.1016/S1471-4914(01)02246-8 Occurrence Handle1:CAS:528:DC%2BD38Xls1CjsA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • CF Lippa K Ozawa DM Mann K Ishii TW Smith S Arawaka H Mori (1999) ArticleTitleDeposition of beta-amyloid subtypes 40 and 42 differentiates dementia with Lewy bodies from Alzheimer disease Arch Neurol 56 1111–1118 Occurrence Handle10488812 Occurrence Handle10.1001/archneur.56.9.1111 Occurrence Handle1:STN:280:DyaK1Mvhs12itw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • SM Lippa CF Lippa H Mori (2005) ArticleTitleAlpha-Synuclein aggregation in pathological aging and Alzheimer’s disease: the impact of beta-amyloid plaque level Am J Alzheimers Dis Other Demen 20 315–318 Occurrence Handle16273997 Occurrence Handle10.1177/153331750502000506

    Article  PubMed  Google Scholar 

  • I Litvan (1997) ArticleTitleProgressive supranuclear palsy and corticobasal degeneration Baill Clin Neurol 6 167–185 Occurrence Handle1:STN:280:DyaK1c%2FovVeisw%3D%3D

    CAS  Google Scholar 

  • I Litvan Y Agid C Goetz J Jankovic GK Wenning JP Brandel EC Lai M Verny K Ray-Chaudhuri A McKee K Jellinger RK Pearce JJ Bartko (1997a) ArticleTitleAccuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study Neurology 48 119–125 Occurrence Handle1:STN:280:DyaK2s7mtFanuw%3D%3D

    CAS  Google Scholar 

  • I Litvan CG Goetz J Jankovic GK Wenning V Booth JJ Bartko A McKee K Jellinger EC Lai JP Brandel M Verny KR Chaudhuri RK Pearce Y Agid (1997b) ArticleTitleWhat is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study Arch Neurol 54 937–944 Occurrence Handle1:STN:280:DyaK2svhtFymtg%3D%3D

    CAS  Google Scholar 

  • OL Lopez I Litvan KE Catt R Stowe W Klunk DI Kaufer JT Becker ST DeKosky (1999) ArticleTitleAccuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias Neurology 53 1292–1299 Occurrence Handle10522887 Occurrence Handle1:STN:280:DyaK1MvltVOhsA%3D%3D

    PubMed  CAS  Google Scholar 

  • OL Lopez JT Becker DI Kaufer RL Hamilton RA Sweet W Klunk ST DeKosky (2002) ArticleTitleResearch evaluation and prospective diagnosis of dementia with Lewy bodies Arch Neurol 59 43–46 Occurrence Handle11790229 Occurrence Handle10.1001/archneur.59.1.43

    Article  PubMed  Google Scholar 

  • W Marui E Iseki M Kato H Akatsu K Kosaka (2004) ArticleTitlePathological entity of dementia with Lewy bodies and its differentiation from Alzheimer’s disease Acta Neuropathol (Berl) 108 121–128

    Google Scholar 

  • E Masliah A Iwai M Mallory K Ueda T Saitoh (1996) ArticleTitleAltered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer’s disease Am J Pathol 148 201–210 Occurrence Handle8546207 Occurrence Handle1:STN:280:DyaK287jtlSqsQ%3D%3D

    PubMed  CAS  Google Scholar 

  • FL Mastaglia RD Johnsen ML Byrnes BA Kakulas (2003) ArticleTitlePrevalence of amyloid-beta deposition in the cerebral cortex in Parkinson’s disease Mov Disord 18 81–86 Occurrence Handle12518303 Occurrence Handle10.1002/mds.10295

    Article  PubMed  Google Scholar 

  • IG McKeith D Galasko K Kosaka EK Perry DW Dickson LA Hansen DP Salmon J Lowe SS Mirra EJ Byrne G Lennox NP Quinn JA Edwardson PG Ince C Bergeron A Burns BL Miller S Lovestone D Collerton EN Jansen C Ballard RA de Vos GK Wilcock KA Jellinger RH Perry (1996) ArticleTitleConsensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1113–1124 Occurrence Handle8909416 Occurrence Handle1:STN:280:DyaK2s%2FmsF2gtw%3D%3D

    PubMed  CAS  Google Scholar 

  • IG McKeith DW Dickson J Lowe M Emre JT O’Brien H Feldman J Cummings JE Duda C Lippa EK Perry D Aarsland H Arai CG Ballard B Boeve DJ Burn D Costa T Del Ser B Dubois D Galasko S Gauthier CG Goetz E Gomez-Tortosa G Halliday LA Hansen J Hardy T Iwatsubo RN Kalaria D Kaufer RA Kenny A Korczyn K Kosaka VMY Lee A Lees I Litvan E Londos OL Lopez S Minoshima Y Mizuno JA Molina EB Mukaetova-Ladinska F Pasquier RH Perry JB Schulz JQ Trojanowski M Yamada InstitutionalAuthorNamefor the Consortium on DLB (2005) ArticleTitleDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium Neurology 65 1863–1872 Occurrence Handle16237129 Occurrence Handle10.1212/01.wnl.0000187889.17253.b1 Occurrence Handle1:STN:280:DC%2BD2Mnpt1GqsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan (1984) ArticleTitleClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease Neurology 34 939–944 Occurrence Handle6610841 Occurrence Handle1:STN:280:DyaL2c3ks1altQ%3D%3D

    PubMed  CAS  Google Scholar 

  • P Mehta T Pirttila (2005) ArticleTitleIncreased cerebrospinal fluid Aβ38/Aβ42 ratio in Alzheimer disease Neurodegen Dis 2 242–245 Occurrence Handle10.1159/000090363 Occurrence Handle1:CAS:528:DC%2BD28Xis1aktro%3D

    Article  CAS  Google Scholar 

  • AR Merdes LA Hansen DV Jeste D Galasko CR Hofstetter GJ Ho LJ Thal J Corey-Bloom (2003) ArticleTitleInfluence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies Neurology 60 1586–1590 Occurrence Handle12771246 Occurrence Handle1:STN:280:DC%2BD3s3kvVWqsw%3D%3D

    PubMed  CAS  Google Scholar 

  • Mollenhauer B, Cullen V, Krastins B, Trenkwalder C, Sarracino DA, Schlossmacher H (2006) Characterisation and quantification of α-synuclein release into cell cultured medium and cerebrospinal fluid. Mov Disord 21 Suppl 15 (72)

  • H Mori M Oda T Komori N Arai M Takanashi T Mizutani S Hirai Y Mizuno (2002) ArticleTitleLewy bodies in progressive supranuclear palsy Acta Neuropathol (Berl) 104 273–278 Occurrence Handle1:CAS:528:DC%2BD38Xls12nsbg%3D

    CAS  Google Scholar 

  • R Motter C Vigo-Pelfrey D Kholodenko R Barbour K Johnson-Wood D Galasko L Chang B Miller C Clark R Green et al. (1995) ArticleTitleReduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease Ann Neurol 38 643–648 Occurrence Handle7574461 Occurrence Handle10.1002/ana.410380413 Occurrence Handle1:STN:280:DyaK28%2FgtFahsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • M Noguchi M Yoshita Y Matsumoto K Ono K Iwasa M Yamada (2005) ArticleTitleDecreased beta-amyloid peptide(42) in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration J Neurol Sci 237 61–65 Occurrence Handle15992827 Occurrence Handle10.1016/j.jns.2005.05.015 Occurrence Handle1:CAS:528:DC%2BD2MXhtVens7%2FK

    Article  PubMed  CAS  Google Scholar 

  • M Otto H Esselmann W Schulz-Shaeffer M Neumann A Schroter P Ratzka L Cepek I Zerr P Steinacker O Windl J Kornhuber HA Kretzschmar S Poser J Wiltfang (2000) ArticleTitleDecreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Neurology 54 1099–1102 Occurrence Handle10720281 Occurrence Handle1:CAS:528:DC%2BD3cXitFalu7g%3D

    PubMed  CAS  Google Scholar 

  • SR Paik JH Lee DH Kim CS Chang YS Kim (1998) ArticleTitleSelf-oligomerization of NACP the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer’s disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25–35) FEBS Lett 421 73–76 Occurrence Handle9462843 Occurrence Handle10.1016/S0014-5793(97)01537-8 Occurrence Handle1:CAS:528:DyaK1cXislOqtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • M Palmblad A Westlind-Danielsson J Bergquist (2002) ArticleTitleOxidation of methionine 35 attenuates formation of amyloid beta-peptide 1-40 oligomers J Biol Chem 277 19506–19510 Occurrence Handle11912198 Occurrence Handle10.1074/jbc.M112218200 Occurrence Handle1:CAS:528:DC%2BD38XksVWlurc%3D

    Article  PubMed  CAS  Google Scholar 

  • L Parkkinen T Kauppinen T Pirttila JM Autere I Alafuzoff (2005) ArticleTitleAlpha-synuclein pathology does not predict extrapyramidal symptoms or dementia Ann Neurol 57 82–91 Occurrence Handle15562510 Occurrence Handle10.1002/ana.20321 Occurrence Handle1:CAS:528:DC%2BD2MXpsFSktQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • O Pletnikova N West MK Lee GL Rudow RL Skolasky TM Dawson L Marsh JC Troncoso (2005) ArticleTitleA[beta] deposition is associated with enhanced cortical [alpha]-synuclein lesions in Lewy body diseases Neurobiol Aging 26 1183–1192 Occurrence Handle15917102 Occurrence Handle10.1016/j.neurobiolaging.2004.10.006 Occurrence Handle1:CAS:528:DC%2BD2MXks1CntLs%3D

    Article  PubMed  CAS  Google Scholar 

  • J Primavera BX Lu PJ Riskind M Iulian SM De La Monte (1999) ArticleTitleBrain accumulation of amyloid-beta in non-Alzheimer neurodegeneration J Alzheimers Dis 1 183–193 Occurrence Handle12214003 Occurrence Handle1:CAS:528:DC%2BD3MXkvFyitA%3D%3D

    PubMed  CAS  Google Scholar 

  • NP Quinn (2005) ArticleTitleHow to diagnose multiple system atrophy Mov Disord 20 IssueIDSuppl 12 S5–S10 Occurrence Handle16092074 Occurrence Handle10.1002/mds.20534

    Article  PubMed  Google Scholar 

  • EM Ribe M Perez B Puig I Gich F Lim M Cuadrado T Sesma S Catena B Sanchez M Nieto (2005) ArticleTitleAccelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice Neurobiol Dis 20 814–822 Occurrence Handle16125396 Occurrence Handle10.1016/j.nbd.2005.05.027 Occurrence Handle1:CAS:528:DC%2BD2MXht1egsbzJ

    Article  PubMed  CAS  Google Scholar 

  • S Sasaki S Maruyama C Toyoda (1991) ArticleTitleA case of progressive supranuclear palsy with widespread senile plaques J Neurol 238 345–348 Occurrence Handle1940988 Occurrence Handle10.1007/BF00315336 Occurrence Handle1:STN:280:DyaK38%2FksVKgtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • Schlossmacher MG (2006) Monitoring of alpha-synuclein steady-state levels in vivo by ELISA. Mov Disord 21 Suppl 13 (026)

  • JA Schneider RL Watts M Gearing RP Brewer SS Mirra (1997) ArticleTitleCorticobasal degeneration: neuropathologic and clinical heterogeneity Neurology 48 959–969 Occurrence Handle9109885 Occurrence Handle1:STN:280:DyaK2s3msVSisQ%3D%3D

    PubMed  CAS  Google Scholar 

  • MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes M Goedert (1997) ArticleTitleAlpha-synuclein in Lewy bodies Nature 388 839–840 Occurrence Handle9278044 Occurrence Handle10.1038/42166 Occurrence Handle1:CAS:528:DyaK2sXlslWru7o%3D

    Article  PubMed  CAS  Google Scholar 

  • D Strozyk K Blennow LR White LJ Launer (2003) ArticleTitleCSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study Neurology 60 652–656 Occurrence Handle12601108 Occurrence Handle1:STN:280:DC%2BD3s%2FovF2gtw%3D%3D

    PubMed  CAS  Google Scholar 

  • YH Suh F Checler (2002) ArticleTitleAmyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer’s disease Pharmacol Rev 54 469–525 Occurrence Handle12223532 Occurrence Handle10.1124/pr.54.3.469 Occurrence Handle1:CAS:528:DC%2BD38XotVSmsr0%3D

    Article  PubMed  CAS  Google Scholar 

  • A Takeda M Mallory M Sundsmo W Honer L Hansen E Masliah (1998) ArticleTitleAbnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders Am J Pathol 152 367–372 Occurrence Handle9466562 Occurrence Handle1:STN:280:DyaK1c7is1Sgug%3D%3D

    PubMed  CAS  Google Scholar 

  • Uchikado H, Delledonne A, Uitti R, Dickson DW (2006) Coexistence of PSP and MSA: a case report and review of the literature. Acta Neuropathol (Berl): 1–7

  • K Urasaki K Kuriki M Namerikawa S Satoh K Ikeguchi M Fukayama K Saito I Nakano (2000) ArticleTitleAn autopsy case of Alzheimer’s disease with a progressive supranuclear palsy overlap Neuropathology 20 233–238 Occurrence Handle11132941 Occurrence Handle10.1046/j.1440-1789.2000.00334.x Occurrence Handle1:STN:280:DC%2BD3M7lt1ygtA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  • MM Verbeek WF Abdo D De Jong MW Horstink BP Kremer BR Bloem (2004) ArticleTitleCerebrospinal fluid Abeta42 levels in multiple system atrophy Mov Disord 19 238–240 Occurrence Handle14978688 Occurrence Handle10.1002/mds.10687

    Article  PubMed  Google Scholar 

  • J Wiltfang A Smirnov B Schnierstein G Kelemen U Matthies HW Klafki M Staufenbiel G Huther E Ruther J Kornhuber (1997) ArticleTitleImproved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43 Electrophoresis 18 527–532 Occurrence Handle9150936 Occurrence Handle10.1002/elps.1150180332 Occurrence Handle1:CAS:528:DyaK2sXjtlKnsLw%3D

    Article  PubMed  CAS  Google Scholar 

  • J Wiltfang H Esselmann P Cupers M Neumann H Kretzschmar M Beyermann D Schleuder H Jahn E Ruther J Kornhuber W Annaert B De Strooper P Saftig (2001) ArticleTitleElevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer’s disease and its generation in PS1 knockout cells J Biol Chem 276 42645–42657 Occurrence Handle11526104 Occurrence Handle10.1074/jbc.M102790200 Occurrence Handle1:CAS:528:DC%2BD3MXptlemurw%3D

    Article  PubMed  CAS  Google Scholar 

  • J Wiltfang H Esselmann M Bibl A Smirnov M Otto S Paul B Schmidt HW Klafki M Maler T Dyrks M Bienert M Beyermann E Ruther J Kornhuber (2002) ArticleTitleHighly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer’s disease and in patients with chronic neuroinflammation J Neurochem 81 481–496 Occurrence Handle12065657 Occurrence Handle10.1046/j.1471-4159.2002.00818.x Occurrence Handle1:CAS:528:DC%2BD38XjsFGktrc%3D

    Article  PubMed  CAS  Google Scholar 

  • J Wiltfang H Esselmann A Smirnov M Bibl L Cepek P Steinacker B Mollenhauer K Buerger H Hampel S Paul M Neumann M Maler I Zerr J Kornhuber HA Kretzschmar S Poser M Otto (2003) ArticleTitleBeta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Ann Neurol 54 263–267 Occurrence Handle12891683 Occurrence Handle10.1002/ana.10661 Occurrence Handle1:CAS:528:DC%2BD3sXmslCqs78%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mollenhauer, B., Bibl, M., Esselmann, H. et al. Tauopathies and synucleinopathies: Do cerebrospinal fluid β-amyloid peptides reflect disease-specific pathogenesis?. J Neural Transm 114, 919–927 (2007). https://doi.org/10.1007/s00702-007-0629-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-007-0629-4

Navigation